NSE · AI Signal & Stock Analysis · Neutral
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for EMCURE is Neutral → (mild move); technical trend raise-2026-09-04; trading at ₹1,926.80 (-0.04% today); neutral (RSI 58).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Neutral → · Mild move |
|---|---|
| Technical trend | RAISE-2026-09-04 |
| Price | ₹1,926.80 |
| Change today | -0.04% |
| RSI (14) | 58.00 |
| Relative volume | 0.65 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹36,572 Cr |
| P/E | 36.07 |
| Cap category | Large Cap |
| 52-week high | -3.9% away |
| 52-week low | +51.5% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for EMCURE (Emcure Pharmaceuticals Limited) is Neutral with a mild move, and its technical trend is raise-2026-09-04. The composite score and full factor breakdown are available to signed-in members.
EMCURE's RSI is neutral (RSI 58). A reading above 70 is typically overbought and below 30 oversold.
EMCURE is trading about 4% below its 52-week high and 52% above its 52-week low as of Sep 28 2026, 6:47 PM.
EMCURE's market capitalisation is ₹36,572 Cr as of Sep 28 2026, 6:47 PM.
EMCURE is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for EMCURE — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.